Stockreport

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced [Read more]